Yoko Fujii

Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial

Adrian Boswood, Jens Häggström, Sonya G. Gordon et al. · Journal of Veterinary Internal Medicine · 2016 · 319 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study

Philip R. Fox, Bruce W. Keene, Kenneth Lamb et al. · Journal of Veterinary Internal Medicine · 2018 · 152 citations · Full text

Medicine, Cardiology, Veterinary Epidemiology +14

Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy

Tomoko Tani, Kazuaki Tanabe, Miwa Ono et al. · Journal of the American Society of Echocardiography · 2004 · 145 citations

Medicine, Cardiology, Clinical Cardiology +10

The analysis of mitral annular disjunction detected by echocardiography and comparison with previously reported pathological data

Toshiko Konda, Tomoko Tani, Naoko Suganuma et al. · Journal of Echocardiography · 2017 · 94 citations

Medicine, Cardiology, Diagnostic Imaging +7

Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study

Adrian Boswood, Sonya G. Gordon, Jens Häggström et al. · Journal of Veterinary Internal Medicine · 2017 · 78 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14